10x Genomics Retained Earnings (Accumulated Deficit) 2018-2024 | TXG

10x Genomics retained earnings (accumulated deficit) from 2018 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
10x Genomics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-1,284
2022 $-1,029
2021 $-863
2020 $-805
2019 $-262
2018 $-231
2017 $
10x Genomics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-09-30 $-1,418
2024-06-30 $-1,382
2024-03-31 $-1,344
2023-12-31 $-1,284
2023-09-30 $-1,235
2023-06-30 $-1,142
2023-03-31 $-1,080
2022-12-31 $-1,029
2022-09-30 $-1,012
2022-06-30 $-970
2022-03-31 $-906
2021-12-31 $-863
2021-09-30 $-845
2021-06-30 $-828
2021-03-31 $-817
2020-12-31 $-805
2020-09-30 $-390
2020-06-30 $-324
2020-03-31 $-284
2019-12-31 $-262
2019-09-30
2019-06-30
2019-03-31
2018-12-31 $-231
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.643B $0.619B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Inspire Medical Systems (INSP) United States $5.276B 164.53
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00